研究者業績

楯 真一

タテ シンイチ  (Shinichi Tate)

基本情報

所属
千葉大学 大学院医学研究院発生・再建医学研究部門発生医学講座生殖機能病態学 講師

J-GLOBAL ID
201001007522201913
researchmap会員ID
6000022325

論文

 58
  • TOMOE YAZAKI, AYUMU MATSUOKA, SHINICHI TATE, KYOKO NISHIKIMI, RIE OKUYA, SATOYO OTSUKA, KAORI KOGA, HIROKAZU USUI
    Cancer Diagnosis & Prognosis 4(4) 454-458 2024年7月1日  
    Background/Aim: Upper gastrointestinal obstruction is an extremely rare complication of primary ovarian cancer. We present a case of primary advanced ovarian cancer with gastroduodenal obstruction successfully managed with neoadjuvant chemotherapy (NAC) and conservative treatment. Case Report: A 60-year-old woman was referred to our hospital for advanced ovarian cancer with upper gastrointestinal obstruction. Computed tomography and endoscopy revealed severe duodenal obstruction caused by dissemination. NAC was initiated with conservative management using a nasogastric tube and total parenteral nutrition (TPN). She was able to eat and TPN was stopped after three months. Complete resection was achieved with interval debulking surgery (IDS) not involving pancreatoduodenectomy, which would have been necessary for primary debulking surgery. There were no serious postoperative complications. Conclusion: NAC with conservative management can improve upper gastrointestinal obstruction in patients with primary advanced ovarian cancer. Furthermore, IDS is expected to allow complete resection, avoiding highly invasive surgeries.
  • Tomoe Yazaki, Ayumu Matsuoka, Shinichi Tate, Kyoko Nishikimi, Rie Okuya, Satoyo Otsuka, Kaori Koga, Hirokazu Usui
    Cancer diagnosis & prognosis 4(4) 454-458 2024年  
    BACKGROUND/AIM: Upper gastrointestinal obstruction is an extremely rare complication of primary ovarian cancer. We present a case of primary advanced ovarian cancer with gastroduodenal obstruction successfully managed with neoadjuvant chemotherapy (NAC) and conservative treatment. CASE REPORT: A 60-year-old woman was referred to our hospital for advanced ovarian cancer with upper gastrointestinal obstruction. Computed tomography and endoscopy revealed severe duodenal obstruction caused by dissemination. NAC was initiated with conservative management using a nasogastric tube and total parenteral nutrition (TPN). She was able to eat and TPN was stopped after three months. Complete resection was achieved with interval debulking surgery (IDS) not involving pancreatoduodenectomy, which would have been necessary for primary debulking surgery. There were no serious postoperative complications. CONCLUSION: NAC with conservative management can improve upper gastrointestinal obstruction in patients with primary advanced ovarian cancer. Furthermore, IDS is expected to allow complete resection, avoiding highly invasive surgeries.
  • Mana Haruishi, Ayumu Matsuoka, Shinichi Tate, Takayuki Arai, Tomohiko Ichikawa, Hirokazu Usui
    The journal of obstetrics and gynaecology research 2023年2月15日  
    Asymptomatic hydronephrosis following hysterectomy is generally transient. Here, we present the case of a 52-year-old woman who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy for benign indications. Computed tomography (CT) to examine bleeding on the second postoperative day incidentally revealed bilateral grade II hydronephrosis. Asymptomatic hydronephrosis was not reevaluated, and gynecological outpatient follow-up was terminated with a normal creatinine level on postoperative day 43. On postoperative day 107, the patient noticed weight gain of 10 kg, decreased urine output, and generalized edema. The serum creatinine level was elevated to 5.4 mg/dL, and CT revealed bilateral grade III hydronephrosis. Urgent bilateral ureteral stenting was performed to treat stenosis of the distal ureters that caused postrenal failure. Ureteroneocystostomy was performed for strict stenosis of the right ureter at 10 months postoperatively. Histological examination of the resected distal ureter showed inflammation and fibrosis. Asymptomatic hydronephrosis developing after hysterectomy progress to delayed postrenal failure.
  • Tatsuya Kobayashi, Kyoko Nishikimi, Akira Mitsuhashi, Hongying Piao, Ayumu Matsuoka, Satoyo Otsuka, Shinichi Tate, Makio Shozu, Hirokazu Usui
    Genes, chromosomes & cancer 2023年1月29日  
    Several cancers harbor "enhancer-type" mutations of the telomerase reverse transcriptase (TERT) promoter for immortalization. Here, we report that 8.6% (8/93) of ovarian clear cell carcinomas (OCCCs) possess the "suppressor-type" TERT promoter mutation. The recurrence rate of OCCCs with "suppressor-type" TERT promoter mutations was 62.5% (5 of 8) and was significantly higher than that of the "unaffected-type" with no mutation (20.8%, 15 of 72) or "enhancer-type" TERT promoter mutations (7.7%, 1 of 13). Our findings show that the acquired suppression of TERT is closely associated with OCCC development and recurrence, indicating the need for further research on telomerase suppression in cancers.
  • 勝浦 瑞貴, 松岡 歩, 楯 真一, 錦見 恭子, 羽生 裕二, 中村 名津子, 奥谷 理恵, 片山 恵里, 大塚 聡代, 碓井 宏和
    関東連合産科婦人科学会誌 59(3) 350-350 2022年10月  

MISC

 98

共同研究・競争的資金等の研究課題

 2